Home Cart 0 Sign in  
X

[ CAS No. 1174046-84-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1174046-84-4
Chemical Structure| 1174046-84-4
Chemical Structure| 1174046-84-4
Structure of 1174046-84-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1174046-84-4 ]

Related Doc. of [ 1174046-84-4 ]

Alternatived Products of [ 1174046-84-4 ]

Product Details of [ 1174046-84-4 ]

CAS No. :1174046-84-4 MDL No. :MFCD18911742
Formula : C10H13NO4 Boiling Point : -
Linear Structure Formula :- InChI Key :CKTIVXCUXUFKSO-UHFFFAOYSA-N
M.W : 211.22 Pubchem ID :53393185
Synonyms :

Calculated chemistry of [ 1174046-84-4 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.4
Num. rotatable bonds : 5
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 54.45
TPSA : 68.39 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.1 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.92
Log Po/w (XLOGP3) : 0.69
Log Po/w (WLOGP) : 0.95
Log Po/w (MLOGP) : 0.6
Log Po/w (SILICOS-IT) : 2.06
Consensus Log Po/w : 1.24

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.55
Solubility : 5.95 mg/ml ; 0.0282 mol/l
Class : Very soluble
Log S (Ali) : -1.7
Solubility : 4.18 mg/ml ; 0.0198 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.95
Solubility : 0.235 mg/ml ; 0.00111 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.22

Safety of [ 1174046-84-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1174046-84-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1174046-84-4 ]
  • Downstream synthetic route of [ 1174046-84-4 ]

[ 1174046-84-4 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 1345855-03-9 ]
  • [ 1174046-84-4 ]
YieldReaction ConditionsOperation in experiment
67% Reflux [01 03j A mixture of ethyl 2-cyano-5 -(dimethylamino)-3 -ethoxypenta-2,4-dienoate (15 Og, 0.63 mol) and HOAc (600 mL) was refluxed overnight. The mixture was cooled to RT, concentrated to dryness, treated with water and washed with EtOAc (2x). The aqueous layer was made basic (pH=9-10) with NaHCO3, extracted with DCM (3x) and the combined organics were washed with brine, dried over Na2SO4, concentrated and purified by silica gel chromatography to afford ethyl 4-ethoxy-2-oxo- 1 ,2-dihydropyridine-3 -carboxylate (90 g, 67percent yield).
66.6%
Stage #1: Reflux
Stage #2: With sodium hydrogencarbonate In water
A mixture of ethyl 2-cyano-5-(dimethylamino)-3-ethoxypenta-2,4-dienoate (150g, 0.63 mol) and HOAc (600 mL) was refluxed overnight. The mixture was concentrated to dryness under high vacuum and the residue treated with water (300 mL). The mixture was extracted with EtOAc (2 x 250 mL) to remove the impurities. The pH of the aqueous was adjusted with NaHC03 to pH - 9- 10. The mixture was extracted with CH2C12 (3 x 300 mL). The combined organics were washed with brine, dried over Na2S04 and concentrated. The residue was purified by silica gel chromatography to afford ethyl 4-ethoxy-2-oxo- l ,2- dihydropyridine-3-carboxylate (90 g, 66.6percent yield).
90 g Reflux A mixture of ethyl 2-cyano-5-(dimethylamino)-3-ethoxypenta-2,4-dienoate (150g, 0.63 mol) and HOAc (600 mL) was refluxed overnight. The mixture was concentrated to dryness under high vacuum, treated with water (300 mL) and washed with EtOAc (2 x 250 mL) to remove the impurities. The pH of the aqueous was adjusted with NaHC03 to pH - 9-10. The mixture was extracted with DCM (3 x 300 mL). The combined organics were washed with brine, dried over Na2S04 and concentrated. The residue was purified by silica gel chromatography to afford ethyl 4-ethoxy-2-oxo-l ,2-dihydropyridine-3-carboxylate (90 g, 66.6percent yield).
Reference: [1] Patent: WO2014/145004, 2014, A1, . Location in patent: Paragraph 0103
[2] Patent: WO2011/139891, 2011, A1, . Location in patent: Page/Page column 59
[3] Patent: WO2013/78295, 2013, A2, . Location in patent: Paragraph 00184
  • 2
  • [ 78-39-7 ]
  • [ 105-56-6 ]
  • [ 1188-33-6 ]
  • [ 1174046-84-4 ]
YieldReaction ConditionsOperation in experiment
26%
Stage #1: at 120℃; for 12 h;
Stage #2: at 70℃; for 2 h;
Ethyl cyanoacetate 70.5 mL (0.66 mol) of triethyl ortho-acetate in 249.6 mL (1.32 mmol), acetic acid 19.6 mL (0.33 mol) into a 120 after 12 hours stirring. Concentrating the solvent of the reaction mixture, it was added DEA-DMF (N, N- dimethylformamide diethyl acetal) 141 mL (0.55 mol). At 70 was stirred for at least 2 hours. To the reaction mixture Place 500 mL of distilled water and 60 mL of acetic acid was refluxed for 12 hours or more. The reaction mixture was cooled to ambient temperature, it was added a saturated aqueous solution of sodium hydrogen carbonate and water. Of dichloromethane and methanol, 9: 1 and extracted with a mixed solvent. The organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. Add 100 mL ethyl acetate and concentrated. At this time, the generated gas by filtration to give the compound methyl 4-methoxy-2-oxo-1,2-dihydropyridine-3-carboxylate 37 g (26percent).
26%
Stage #1: at 120℃; for 12 h;
Stage #2: at 70℃; for 2 h;
Stage #3: With acetic acid In water for 12 h; Reflux
Ethyl cyanoacetate (70.5 mL, 0.66 mol) was added with triethyl orthoacetate (249.6 mL, 1.32 mmol) and acetic acid (19.6 mL, 0.33 mol) and stirred at 120°C for at least 12 hours. The solvent of the reaction mixture was concentrated and added with N,N-dimethylformamide diethylacetal (DMF-DEA) (141 mL, 0.55 mol) and stirred at 70°C for at least 2 hours. The reaction mixture was added with acetic acid (500 mL) and distilled water (60 mL) and refluxed for at least 12 hours. The reaction mixture was cooled to room temperature and added with a saturated aqueous solution of sodium hydrogen carbonate and water. The resultant was extracted using a mixed solvent (dichloromethane : methanol = 9 : 1). The resulting organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The resultant was added with ethyl acetate (100 mL) and concentrated. The thus-obtained solid was filtered to obtain 37 g (26percent) of ethyl 4-ethoxy-2-oxo-1,2-dihydropyridin-3-carboxylate.
26%
Stage #1: at 120℃; for 12 h;
Stage #2: at 70℃; for 2 h;
Stage #3: With acetic acid In water for 12 h; Reflux
Ethyl cyanoacetate (70.5 mL, 0.66 mol) was added with triethyl orthoacetate (249.6 mL, 1.32 mmol) and acetic acid (19.6 mL, 0.33 mol) and stirred at 120° C. for at least 12 hours.
The solvent of the reaction mixture was concentrated and added with N,N-dimethylformamide diethylacetal (DMF-DEA) (141 mL, 0.55 mol) and stirred at 70° C. for at least 2 hours.
The reaction mixture was added with acetic acid (500 mL) and distilled water (60 mL) and refluxed for at least 12 hours.
The reaction mixture was cooled to room temperature and added with a saturated aqueous solution of sodium hydrogen carbonate and water.
The resultant was extracted using a mixed solvent (dichloromethane:methanol=9:1).
The resulting organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure.
The resultant was added with ethyl acetate (100 mL) and concentrated.
The thus-obtained solid was filtered to obtain 37 g (26percent) of ethyl 4-ethoxy-2-oxo-1,2-dihydropyridin-3-carboxylate.
1H NMR (400 MHz, DMSO-d6) δ 11.61 (bs, 1H), 7.46 (d, J=7.6 Hz, 1H), 6.21 (d, J=7.6 Hz, 1H), 4.++14 (m, 4H), 1.22 (m, 6H)
MS: 212 [M+H]+
Reference: [1] Patent: KR2016/8142, 2016, A, . Location in patent: Paragraph 0148-0152
[2] Patent: KR101598664, 2016, B1, . Location in patent: Paragraph 0148-0150
[3] Patent: US2016/207931, 2016, A1, . Location in patent: Paragraph 0217; 0218; 0219; 0220
  • 3
  • [ 105-56-6 ]
  • [ 1174046-84-4 ]
Reference: [1] Patent: WO2011/139891, 2011, A1,
[2] Patent: WO2013/78295, 2013, A2,
[3] Patent: WO2014/145004, 2014, A1,
  • 4
  • [ 35260-93-6 ]
  • [ 1174046-84-4 ]
Reference: [1] Patent: WO2011/139891, 2011, A1,
[2] Patent: WO2013/78295, 2013, A2,
[3] Patent: WO2014/145004, 2014, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1174046-84-4 ]

Ethers

Chemical Structure| 53937-02-3

[ 53937-02-3 ]

4-Benzyloxy-2-(1H)-pyridone

Similarity: 0.72

Chemical Structure| 59-06-3

[ 59-06-3 ]

Methyl 4-acetamido-2-ethoxybenzoate

Similarity: 0.71

Chemical Structure| 21642-98-8

[ 21642-98-8 ]

4-Methoxy-2-oxo-1,2-dihydropyridine-3-carbonitrile

Similarity: 0.70

Chemical Structure| 4093-29-2

[ 4093-29-2 ]

Methyl 4-acetamido-2-methoxybenzoate

Similarity: 0.68

Chemical Structure| 379228-26-9

[ 379228-26-9 ]

Methyl 2-amino-4,6-dimethoxybenzoate

Similarity: 0.67

Amides

Chemical Structure| 10128-91-3

[ 10128-91-3 ]

Methyl 2-oxo-1,2-dihydro-3-pyridinecarboxylate

Similarity: 0.83

Chemical Structure| 88612-71-9

[ 88612-71-9 ]

Ethyl 4-oxo-4H-quinolizine-3-carboxylate

Similarity: 0.77

Chemical Structure| 609-71-2

[ 609-71-2 ]

2-Oxo-1,2-dihydropyridine-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 120034-05-1

[ 120034-05-1 ]

Methyl 5-bromo-2-oxo-1,2-dihydropyridine-3-carboxylate

Similarity: 0.73

Chemical Structure| 116387-40-7

[ 116387-40-7 ]

Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate

Similarity: 0.73

Esters

Chemical Structure| 10128-91-3

[ 10128-91-3 ]

Methyl 2-oxo-1,2-dihydro-3-pyridinecarboxylate

Similarity: 0.83

Chemical Structure| 88612-71-9

[ 88612-71-9 ]

Ethyl 4-oxo-4H-quinolizine-3-carboxylate

Similarity: 0.77

Chemical Structure| 120034-05-1

[ 120034-05-1 ]

Methyl 5-bromo-2-oxo-1,2-dihydropyridine-3-carboxylate

Similarity: 0.73

Chemical Structure| 116387-40-7

[ 116387-40-7 ]

Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate

Similarity: 0.73

Chemical Structure| 337909-10-1

[ 337909-10-1 ]

Ethyl 1-formyl-4-oxo-4H-quinolizine-3-carboxylate

Similarity: 0.71

Related Parent Nucleus of
[ 1174046-84-4 ]

Pyridines

Chemical Structure| 10128-91-3

[ 10128-91-3 ]

Methyl 2-oxo-1,2-dihydro-3-pyridinecarboxylate

Similarity: 0.83

Chemical Structure| 609-71-2

[ 609-71-2 ]

2-Oxo-1,2-dihydropyridine-3-carboxylic acid

Similarity: 0.76

Chemical Structure| 120034-05-1

[ 120034-05-1 ]

Methyl 5-bromo-2-oxo-1,2-dihydropyridine-3-carboxylate

Similarity: 0.73

Chemical Structure| 116387-40-7

[ 116387-40-7 ]

Methyl 5-iodo-2-oxo-1,2-dihydropyridine-3-carboxylate

Similarity: 0.73

Chemical Structure| 53937-02-3

[ 53937-02-3 ]

4-Benzyloxy-2-(1H)-pyridone

Similarity: 0.72